X-154860588-C-A
Variant summary
Our verdict is Pathogenic. Variant got 6 ACMG points: 6P and 0B. PS4PP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000132.3(F8):c.6744G>T (p.Trp2248Cys) is reported in at least 19 patients with mild, moderate or severe hemophilia A in the literature reviewed (PMID:17222201, 18691168, 15921397, 1301932, 17610560). There are several additional probands with the variant reported in the EAHAD database, recorded from the literature and unpublished sources. There are also individuals reported with a history of inhibitor development to factor VIII replacement therapy (EAHAD/CDC Champs Databases). The variant is absent from gnomAD v2.1.1 and v3 meeting PM2_Supporting. This missense variant has a REVEL score of 0.925 (>0.6), meeting criteria for PP3. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8/F9: PS4_Very Strong, PP3, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA255218/MONDO:0010602/071
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.6744G>T | p.Trp2248Cys | missense_variant | 25/26 | ENST00000360256.9 | NP_000123.1 | |
F8 | NM_019863.3 | c.339G>T | p.Trp113Cys | missense_variant | 4/5 | NP_063916.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.6744G>T | p.Trp2248Cys | missense_variant | 25/26 | 1 | NM_000132.4 | ENSP00000353393 | P1 | |
F8 | ENST00000330287.10 | c.339G>T | p.Trp113Cys | missense_variant | 4/5 | 1 | ENSP00000327895 | |||
F8 | ENST00000644698.1 | c.477G>T | p.Trp159Cys | missense_variant | 5/6 | ENSP00000495706 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097924Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363280
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1992 | - - |
Pathogenic, reviewed by expert panel | curation | ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen | Feb 02, 2024 | The NM_000132.3(F8):c.6744G>T (p.Trp2248Cys) is reported in at least 19 patients with mild, moderate or severe hemophilia A in the literature reviewed (PMID: 17222201, 18691168, 15921397, 1301932, 17610560). There are several additional probands with the variant reported in the EAHAD database, recorded from the literature and unpublished sources. There are also individuals reported with a history of inhibitor development to factor VIII replacement therapy (EAHAD/CDC Champs Databases). The variant is absent from gnomAD v2.1.1 and v3 meeting PM2_Supporting. This missense variant has a REVEL score of 0.925 (>0.6), meeting criteria for PP3. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8/F9: PS4_Very Strong, PP3, PM2_Supporting. - |
Hereditary factor IX deficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Feb 01, 2019 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 07, 2022 | The F8 c.6744G>T; p.Trp2248Cys variant (rs137852469), also known as W2229C in traditional nomenclature, is reported in the literature in multiple individuals affected with mild to severe hemophilia A (Diamond 1992, Markoff 2009, Naylor 1991, see link to FVIII database). This variant is also reported in ClinVar (Variation ID: 10327). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. The tryptophan at codon 2248 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.925). Additionally, other variants at this codon (c.6742T>A, p.Trp2248Arg; c.6742T>C, p.Trp2248Arg; c.6743G>C p.Trp2248Ser) have been reported in individuals with mild to severe hemophilia A (Markoff 2009, Santacroce 2008, Shinozawa 2021, Yenchitsomanus 2003). Based on available information, this variant is considered to be pathogenic. References: Link to FVIII database: https://f8-db.eahad.org/index.php Diamond C et al. Amino acid substitutions in conserved domains of factor VIII and related proteins: study of patients with mild and moderately severe hemophilia A. Hum Mutat. 1992;1(3):248-57. PMID: 1301932. Markoff A et al. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia. 2009 Jul;15(4):932-41. PMID: 19473423. Naylor JA et al. Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene. Lancet. 1991 Mar 16;337(8742):635-9. PMID: 1671991. Santacroce R et al. Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet. 2008;53(3):275-284. PMID: 18217193. Shinozawa K et al. Spectrum of F8 Genotype and Genetic Impact on Inhibitor Development in Patients with Hemophilia A from Multicenter Cohort Studies (J-HIS) in Japan. Thromb Haemost. 2021 May;121(5):603-615. PMID: 33254277. Yenchitsomanus P et al. Genotype and phenotype of haemophilia A in Thai patients. Haemophilia. 2003 Mar;9(2):179-86. PMID: 12614369. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at